The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture
Clinical trial NCT04702516 · UNKNOWN
Trial details
- NCT number
- NCT04702516
- Sponsor
- Morten Frost
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-24
- Primary completion
- 2022-08-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.